Beyond Air Inc
Research Beyond Air Inc (XAIR) on Bullrun: market cap USD 2.94M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerXAIR
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Market capUSD 2.94M
- Financial periodQ1 2026
- RevenueUSD 1.91M
- Net income-USD 10.28M
- Free cash flow-USD 5.49M
- Gross margin4.9%
Valuation Snapshot
latest market cap is USD 2.94M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 3.71M | -USD 46.63M | -USD 44.10M | -44.9% | -0.69 | USD 4.67M | USD 23.59M | USD 13.58M |
| FY2024 | USD 1.16M | -USD 60.24M | -USD 61.76M | -112.8% | -1.82 | USD 11.38M | USD 17.50M | USD 25.05M |
| FY2023 | n/a | -USD 55.82M | -USD 36.89M | n/a | -1.86 | USD 29.16M | USD 200.00K | USD 37.92M |
| FY2022 | n/a | -USD 43.18M | -USD 24.51M | n/a | n/a | USD 80.24M | USD 200.00K | USD 72.70M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 2.94M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 3.39M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 26.68M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 62.67M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 194.13M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 265.85M | n/a | n/a | n/a |
About Beyond Air Inc
Beyond Air, Inc. operates as a commercial-stage medical device and biopharmaceutical company. It operates through Beyond Air, Beyond Cancer, and NeuroNos segments. The company offers Lungfit PH for the treatment of persistent pulmonary hypertension of the newborn. It is also developing LungFit PRO to treat viral lung infections, such as viral community-acquired pneumonia, including COVID-19 and bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria (NTM).
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Beyond Air Inc's market cap?
Beyond Air Inc's market capitalization is USD 2.94M.
What does Beyond Air Inc do?
Beyond Air, Inc. operates as a commercial-stage medical device and biopharmaceutical company. It operates through Beyond Air, Beyond Cancer, and NeuroNos segments. The company offers Lungfit PH for the treatment of persistent pulmonary hypertension of the newborn. It is also developing LungFit PRO to treat viral lung infections, such as viral community-acquired pneumonia, including COVID-19 and bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria (NTM).